Detalhe da pesquisa
1.
Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL.
Blood
; 143(16): 1616-1627, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38215395
2.
Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial.
Blood
; 141(2): 156-167, 2023 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35714312
3.
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.
Blood
; 140(12): 1345-1377, 2022 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35797463
4.
Follow-up of patients with R/R FLT3-mutation-positive AML treated with gilteritinib in the phase 3 ADMIRAL trial.
Blood
; 139(23): 3366-3375, 2022 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35081255
5.
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.
Blood
; 140(11): 1200-1228, 2022 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35767897
6.
Expedited evaluation of hereditary hematopoietic malignancies in the setting of stem cell transplantation.
Haematologica
; 2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38618681
7.
High-fat diet, but not duration of lactation, increases mammary gland lymphatic vessel function and subsequent growth of inflammatory breast cancer cells.
J Mammary Gland Biol Neoplasia
; 28(1): 21, 2023 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37801190
8.
Durable responses in acute lymphoblastic leukaemia with the use of FLT3 and IDH inhibitors.
Br J Haematol
; 2023 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38073116
9.
Inherited cancer predisposing mutations in patients with therapy-related myeloid neoplasms.
Br J Haematol
; 200(4): 489-493, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36349721
10.
Clonal evolution of acute myeloid leukemia with FLT3-ITD mutation under treatment with midostaurin.
Blood
; 137(22): 3093-3104, 2021 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33598693
11.
Molecular response in newly diagnosed chronic-phase chronic myeloid leukemia: prediction modeling and pathway analysis.
Haematologica
; 108(6): 1567-1578, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36727397
12.
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.
N Engl J Med
; 381(18): 1728-1740, 2019 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31665578
13.
Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia.
Blood
; 135(5): 371-380, 2020 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31826241
14.
Patient- and physician-reported pain after tyrosine kinase inhibitor discontinuation among patients with chronic myeloid leukemia.
Haematologica
; 107(11): 2641-2649, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35511672
15.
Asciminib monotherapy for newly diagnosed chronic myeloid leukemia in chronic phase: the ASC4FIRST phase III trial.
Future Oncol
; 18(38): 4161-4170, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36524980
16.
Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL.
N Engl J Med
; 379(26): 2517-2528, 2018 12 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30501481
17.
A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403.
Blood
; 133(14): 1548-1559, 2019 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30658992
18.
Unexpected Toxicities When Nivolumab Was Given as Maintenance Therapy following Allogeneic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 26(5): 1025-1027, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32018063
19.
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia.
N Engl J Med
; 376(10): 917-927, 2017 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28273028
20.
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation.
N Engl J Med
; 377(5): 454-464, 2017 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28644114